219 related articles for article (PubMed ID: 16184550)
1. KLF5 promotes cell proliferation and tumorigenesis through gene regulation and the TSU-Pr1 human bladder cancer cell line.
Chen C; Benjamin MS; Sun X; Otto KB; Guo P; Dong XY; Bao Y; Zhou Z; Cheng X; Simons JW; Dong JT
Int J Cancer; 2006 Mar; 118(6):1346-55. PubMed ID: 16184550
[TBL] [Abstract][Full Text] [Related]
2. CINP is a novel cofactor of KLF5 required for its role in the promotion of cell proliferation, survival and tumor growth.
Wu Q; Fu C; Li M; Li J; Li Z; Qi L; Ci X; Ma G; Gao A; Fu X; A J; An N; Liu M; Li Y; King JL; Fu L; Zhang B; Dong JT
Int J Cancer; 2019 Feb; 144(3):582-594. PubMed ID: 30289973
[TBL] [Abstract][Full Text] [Related]
3. Beyond proliferation: KLF5 promotes angiogenesis of bladder cancer through directly regulating VEGFA transcription.
Gao Y; Wu K; Chen Y; Zhou J; Du C; Shi Q; Xu S; Jia J; Tang X; Li F; Hui K; He D; Guo P
Oncotarget; 2015 Dec; 6(41):43791-805. PubMed ID: 26544730
[TBL] [Abstract][Full Text] [Related]
4. Krüppel-like factor 5 promotes breast cell proliferation partially through upregulating the transcription of fibroblast growth factor binding protein 1.
Zheng HQ; Zhou Z; Huang J; Chaudhury L; Dong JT; Chen C
Oncogene; 2009 Oct; 28(42):3702-13. PubMed ID: 19668233
[TBL] [Abstract][Full Text] [Related]
5. Klf5 deletion promotes Pten deletion-initiated luminal-type mouse prostate tumors through multiple oncogenic signaling pathways.
Xing C; Ci X; Sun X; Fu X; Zhang Z; Dong EN; Hao ZZ; Dong JT
Neoplasia; 2014 Nov; 16(11):883-99. PubMed ID: 25425963
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: role of fibroblast growth factor receptor-2.
Chaffer CL; Brennan JP; Slavin JL; Blick T; Thompson EW; Williams ED
Cancer Res; 2006 Dec; 66(23):11271-8. PubMed ID: 17145872
[TBL] [Abstract][Full Text] [Related]
7. KLF5 promotes cell migration by up-regulating FYN in bladder cancer cells.
Du C; Gao Y; Xu S; Jia J; Huang Z; Fan J; Wang X; He D; Guo P
FEBS Lett; 2016 Feb; 590(3):408-18. PubMed ID: 26786295
[TBL] [Abstract][Full Text] [Related]
8. KLF5 inhibits angiogenesis in PTEN-deficient prostate cancer by attenuating AKT activation and subsequent HIF1α accumulation.
Ci X; Xing C; Zhang B; Zhang Z; Ni JJ; Zhou W; Dong JT
Mol Cancer; 2015 Apr; 14():91. PubMed ID: 25896712
[TBL] [Abstract][Full Text] [Related]
9. Krüppel-like factor 5 promotes lung tumorigenesis through upregulation of Sox4.
Li Q; Dong Z; Zhou F; Cai X; Gao Y; Wang LW
Cell Physiol Biochem; 2014; 33(1):1-10. PubMed ID: 24401325
[TBL] [Abstract][Full Text] [Related]
10. Kruppel-like factor 5 is not required for K-RasG12D lung tumorigenesis, but represses ABCG2 expression and is associated with better disease-specific survival.
Meyer SE; Hasenstein JR; Baktula A; Velu CS; Xu Y; Wan H; Whitsett JA; Gilks CB; Grimes HL
Am J Pathol; 2010 Sep; 177(3):1503-13. PubMed ID: 20639455
[TBL] [Abstract][Full Text] [Related]
11. Intestinal tumor progression is associated with altered function of KLF5.
Bateman NW; Tan D; Pestell RG; Black JD; Black AR
J Biol Chem; 2004 Mar; 279(13):12093-101. PubMed ID: 14726538
[TBL] [Abstract][Full Text] [Related]
12. KLF5 enhances SREBP-1 action in androgen-dependent induction of fatty acid synthase in prostate cancer cells.
Lee MY; Moon JS; Park SW; Koh YK; Ahn YH; Kim KS
Biochem J; 2009 Jan; 417(1):313-22. PubMed ID: 18774944
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of Krüppel-like factor 5 in pancreatic cancer is promoted by interleukin-1beta signaling and hypoxia-inducible factor-1alpha.
Mori A; Moser C; Lang SA; Hackl C; Gottfried E; Kreutz M; Schlitt HJ; Geissler EK; Stoeltzing O
Mol Cancer Res; 2009 Aug; 7(8):1390-8. PubMed ID: 19671674
[TBL] [Abstract][Full Text] [Related]
14. Krüppel-like factor 5 mediates the transforming activity of oncogenic H-Ras.
Nandan MO; Yoon HS; Zhao W; Ouko LA; Chanchevalap S; Yang VW
Oncogene; 2004 Apr; 23(19):3404-13. PubMed ID: 15077182
[TBL] [Abstract][Full Text] [Related]
15. The tumor-suppressor gene Nkx2.8 suppresses bladder cancer proliferation through upregulation of FOXO3a and inhibition of the MEK/ERK signaling pathway.
Yu C; Zhang Z; Liao W; Zhao X; Liu L; Wu Y; Liu Z; Li Y; Zhong Y; Chen K; Li J; Zhou F; Song L
Carcinogenesis; 2012 Mar; 33(3):678-86. PubMed ID: 22223847
[TBL] [Abstract][Full Text] [Related]
16. YAP promotes breast cell proliferation and survival partially through stabilizing the KLF5 transcription factor.
Zhi X; Zhao D; Zhou Z; Liu R; Chen C
Am J Pathol; 2012 Jun; 180(6):2452-61. PubMed ID: 22632819
[TBL] [Abstract][Full Text] [Related]
17. Aberrant fibroblast growth factor receptor signaling in bladder and other cancers.
Chaffer CL; Dopheide B; Savagner P; Thompson EW; Williams ED
Differentiation; 2007 Nov; 75(9):831-42. PubMed ID: 17697126
[TBL] [Abstract][Full Text] [Related]
18. Cyclin D1b variant promotes cell invasiveness independent of binding to CDK4 in human bladder cancer cells.
Kim CJ; Nishi K; Isono T; Okuyama Y; Tambe Y; Okada Y; Inoue H
Mol Carcinog; 2009 Oct; 48(10):953-64. PubMed ID: 19415719
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway.
Urakami S; Shiina H; Enokida H; Kawakami T; Tokizane T; Ogishima T; Tanaka Y; Li LC; Ribeiro-Filho LA; Terashima M; Kikuno N; Adachi H; Yoneda T; Kishi H; Shigeno K; Konety BR; Igawa M; Dahiya R
Clin Cancer Res; 2006 Jan; 12(2):383-91. PubMed ID: 16428476
[TBL] [Abstract][Full Text] [Related]
20. PTHrP signaling targets cyclin D1 and induces osteoblastic cell growth arrest.
Datta NS; Chen C; Berry JE; McCauley LK
J Bone Miner Res; 2005 Jun; 20(6):1051-64. PubMed ID: 15883646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]